Some European stocks will be protected from Trump: Sam Gleave of Liontrust European Dynamic

In the latest episode of the IC Interviews, Dave Baxter sits down with Sam Gleave of Liontrust’s European Dynamic. The fund seeks out companies lowly valued by investors, but that could generate more cash than they need to sustain strong growth. In the episode, Dave and Sam discuss why the fund is still bullish on European markets, the outlook for banks on the continent, plus how the fund views Hermes (RMS), Novo Nordisk (NOVO.B) and ASML (ASML). The pair also unpack what impact Trump’s swathe of tariffs will have on the fund and European companies at wide. This episode was recorded on 24 January.Timestamps 0:33 2025 outlook 2:57 China plays4:15 Industrials4:52 Luxury7:07 M&A 8:48 Banks12:49 Novo Nordisk (NOVO.B)16:47 ASML (ASML) 18:19 Trump, tariffs and the fund20:13 Publicis (PUB)22:02 Sectors Liontrust are wary of23:24 Is the opportunity set growingClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.